BLOOD DONATION – A VITAL PRACTICE IN THERAPY AND LIFE-SAVING: HEALTH BENEFITS AND IMPACT ON WELL-BEING
DOI:
https://doi.org/10.58407/bht.2.25.2Keywords:
blood donation, cardiovascular health, lipid metabolism, iron regulation, disease prevention, detoxification, cancer risk reductionAbstract
Purpose: The aim of this article is to provide a detailed analysis of the health benefits of blood donation, with particular emphasis on its effects on cardiovascular function, iron regulation, lipid metabolism, blood pressure and the prevention of lifestyle diseases, including myocardial infarction, atherosclerosis, coronary heart disease and cancer. In addition, the detoxifying effects of blood donation are presented, including the elimination of toxins from the body, such as perfluoroalkyl substances (PFAS).
Materials and methods. To obtain accurate and comprehensive information on the health aspects of blood donation, a review of the available scientific literature was conducted. The search included databases such as PubMed, Scopus, Web of Science and Google Scholar. The material analysed included scientific articles, clinical research reports, systematic reviews and reports on the role of blood donation in therapy and life-saving, with a particular focus on its benefits, procedures and impact on donor health. The article is based on a review of the available scientific studies and literature, including experimental and epidemiological findings, that indicate the positive effects of regular blood donation. Literature sources include studies on blood donation as well as a wide range of literature on cardiovascular, metabolic, oncological diseases and body detoxification. Data from international health organisations and medical guidelines on blood donation procedures were also included.
Scientific novelty. The study presents an innovative perspective on the health benefits of blood donation, emphasising its role not only in saving the lives of recipients, but also in preventing and treating disease in donors. The article presents research and analysis that highlights the surprising health benefits for individuals who donate blood regularly. It integrates research from a range of medical disciplines, highlighting multidimensional health benefits that go beyond the traditional understanding of blood transfusion. It also provides new information on the role of blood donation in detoxifying the body and its potential to reduce the risk of chronic diseases such as atherosclerosis and cancer.
Conclusions. Regular blood donation has a positive effect on the cardiovascular system, reducing the risk of heart disease by lowering iron levels and improving lipid metabolism. Blood donation helps maintain appropriate iron levels, reducing the risk of cardiovascular disease and excessive accumulation of this element, which is harmful to the body. Regular blood donation can reduce the risk of heart attack by influencing cholesterol levels and improving the condition of blood vessels. There is evidence that donating blood can lower blood pressure, especially in people with hypertension. Blood donation helps to reduce the risk of atherosclerosis by improving the lipid profile and lowering levels of 'bad' LDL cholesterol. Regular blood donation improves cardiovascular health and reduces the risk of coronary heart disease. Blood donation can help prevent metabolic syndrome, including improving insulin sensitivity and lowering blood glucose levels. The body's ability to regulate blood lipid levels increases, reducing the risk of diseases associated with excess fat in the body. Regular blood donation helps remove toxic substances, such as PFAS, that can accumulate in the human body. Data suggests that blood donation may reduce the risk of developing certain types of cancer, particularly by improving the body's overall condition and eliminating toxins. Blood donation is not only vital for saving lives, but can also be an effective preventive measure in the treatment and prevention of lifestyle diseases. Studies show a wide range of health benefits that can improve quality of life and reduce the risk of many serious diseases.
Downloads
References
Abolghasemi, H., Hosseini-Divkalayi, N. S., & Seighali, F. (2010). Blood donor incentives: A step forward or backward. Asian journal of transfusion science, 4(1), 9–13. https://doi.org/10.4103/0973-6247.59385
Agudo, A., Bonet, C., Sala, N., Muñoz, X., Aranda, N., Fonseca-Nunes, A., Clavel-Chapelon, F., Boutron-Ruault, M. C., Vineis, P., Panico, S., Palli, D., Tumino, R., Grioni, S., Quirós, J. R., Molina, E., Navarro, C., Barricarte, A., Chamosa, S., Allen, N. E., Khaw, K. T., … Jakszyn, P. (2013). Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Carcinogenesis, 34(6), 1244–1250. https://doi.org/10.1093/carcin/bgt045
Alloubani, A., Nimer, R., & Samara, R. (2021). Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review. Current cardiology reviews, 17(6), e051121189015. https://doi.org/10.2174/1573403X16999201210200342
Amrein, K., Valentin, A., Lanzer, G., & Drexler, C. (2012). Adverse events and safety issues in blood donation – a comprehensive review. Blood reviews, 26(1), 33–42. https://doi.org/10.1016/j.blre. 2011.09.003
Ansell, B. J., Fonarow, G. C., & Fogelman, A. M. (2007). The paradox of dysfunctional high-density lipoprotein. Current opinion in lipidology, 18(4), 427–434. https://doi.org/10.1097/MOL.0b013 e3282364a17
Ansell, B. J., Watson, K. E., Fogelman, A. M., Navab, M., & Fonarow, G. C. (2005). High-density lipo-protein function recent advances. Journal of the American College of Cardiology, 46(10), 1792–1798. https://doi.org/10.1016/j.jacc.2005.06.080
Araki, T., Ishikawa, Y., Okazaki, H., Tani, Y., Toyooka, S., Satake, M., Miwa, U., Tadokoro, K., & Japanese Red Cross GA Research Group (2012). Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan. Journal of diabetes investigation, 3(6), 492–497. https://doi.org/10.1111/j.2040-1124.2012.00224.x
Ariyanti, R., & Besral, B. (2019). Dyslipidemia Associated with Hypertension Increases the Risks for Coronary Heart Disease: A Case-Control Study in Harapan Kita Hospital, National Cardiovascular Center, Jakarta. Journal of lipids, 2019, 2517013. https://doi.org/10.1155/2019/2517013
Ascherio, A., Rimm, E. B., Giovannucci, E., Willett, W. C., & Stampfer, M. J. (2001). Blood donations and risk of coronary heart disease in men. Circulation, 103(1), 52–57. https://doi.org/10.1161/ 01.cir.103.1.52
Atsma, F., Veldhuizen, I., de Vegt, F., Doggen, C., & de Kort, W. (2011a). Cardiovascular and demographic characteristics in whole blood and plasma donors: results from the Donor InSight study. Transfusion, 51(2), 412–420. https://doi.org/10.1111/j.1537-2995.2010.02867.x
Atsma, F., Veldhuizen, I., Verbeek, A., de Kort, W., & de Vegt, F. (2011b). Healthy donor effect: its magnitude in health research among blood donors. Transfusion, 51(8), 1820–1828. https://doi.org/ 10.1111/j.1537-2995.2010.03055.x
Balaskas, S., Rigou, M., Xenos, M., & Mallas, A. (2024). Behavioral Intentions to Donate Blood: The Interplay of Personality, Emotional Arousals, and the Moderating Effect of Altruistic versus Egoistic Messages on Young Adults. Behavioral sciences (Basel, Switzerland), 14(8), 731. https://doi.org/ 10.3390/bs14080731
Bandeali, S., & Farmer, J. (2012). High-density lipoprotein and atherosclerosis: the role of antioxidant activity. Current atherosclerosis reports, 14(2), 101–107. https://doi.org/10.1007/s11883-012-0235-2
Bandyopadhyay, S., Brittenham, G. M., Francis, R. O., Zimring, J. C., Hod, E. A., & Spitalnik, S. L. (2017). Iron-deficient erythropoiesis in blood donors and red blood cell recovery after transfusion: initial studies with a mouse model. Blood transfusion = Trasfusione del sangue, 15(2), 158–164. https:// doi.org/10.2450/2017.0349-16
Bani-Ahmad, M. A., Khabour, O. F., Gharibeh, M. Y., & Alshlool, K. N. (2017). The impact of multiple blood donations on the risk of cardiovascular diseases: Insight of lipid profile. Transfusion clinique et biologique: journal de la Societe francaise de transfusion sanguine, 24(4), 410–416. https://doi.org/ 10.1016/j.tracli.2017.07.001
Basuli, D., Stevens, R. G., Torti, F. M., & Torti, S. V. (2014). Epidemiological associations between iron and cardiovascular disease and diabetes. Frontiers in pharmacology, 5, 117. https://doi.org/ 10.3389/fphar.2014.00117
Becker R. C. (1993). The role of blood viscosity in the development and progression of coronary artery disease. Cleveland Clinic journal of medicine, 60(5), 353–358. https://doi.org/10.3949/ ccjm.60.5.353
Bhuiyea, M. S. H., Faiyaz, S. R., Jaman, N., & Uddin, M. J. (2022). Factors influencing voluntary blood donation practice among university students of Bangladesh. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis, 61(4), 103379. https://doi.org/10.1016/j.transci.2022.103379
Blood Donor Selection: Guidelines on Assessing Donor Suitability for Blood Donation. Geneva: World Health Organization; 2012. 3, Assessing donor suitability. Available from: https://www. ncbi.nlm.nih.gov/books/NBK138211/
Blood Donor Selection: Guidelines on Assessing Donor Suitability for Blood Donation. Geneva: World Health Organization; 2012. 4, General donor assessment. Available from: https://www.ncbi.nlm. nih.gov/books/NBK138219/
Borai, A., Livingstone, C., Farzal, A., Baljoon, D., Al Sofyani, A., Bahijri, S., Kadam, I., Hafiz, K., Abdelaal, M., & Ferns, G. (2016). Changes in metabolic indices in response to whole blood donation in male subjects with normal glucose tolerance. Clinical biochemistry, 49(1-2), 51–56. https://doi.org/ 10.1016/j.clinbiochem.2015.08.023
Brittenham G. M. (2011). Iron deficiency in whole blood donors. Transfusion, 51(3), 458–461. https://doi.org/10.1111/j.1537-2995.2011.03062.x
Bukar, A., Ajayi, O. I., Obi, S., Olaniyam. M.F., Abba, A., Aladenika, S., Osakue, E. O., Jeremiah, Z. A., Waziri, G., Medugu, J. T., Geidam, U., Audu, N., Abja, U. M., Wurno, M. (2016). Effects of Blood Donations on Haemorheology: A study on Blood Donors in Wurno Maternity Clinic, Babaldu. Sokoto journal of medical laboratory science, 1(1), 152–155
Calabresi, L., Gomaraschi, M., & Franceschini, G. (2003). Endothelial protection by high-density lipoproteins: from bench to bedside. Arteriosclerosis, thrombosis, and vascular biology, 23(10), 1724–1731. https://doi.org/10.1161/01.ATV.0000094961.74697.54
Casiglia, E., Biasin, R., Cavatton, G., Capuani, M., Marotti, A., Onesto, C., Tramontin, P., & Pessina, A. C. (1996). Lower blood pressure values in blood donors? Japanese heart journal, 37(6), 897–903. https://doi.org/10.1536/ihj.37.897
Choudhury, D., Tuncel, M., & Levi, M. (2009). Disorders of lipid metabolism and chronic kidney disease in the elderly. Seminars in nephrology, 29(6), 610–620. https://doi.org/10.1016/ j.semnephrol.2009.07.006
Coban, E., Alkan, E., Altuntas, S., & Akar, Y. (2010). Serum ferritin levels correlate with hypertensive retinopathy. Medical science monitor: international medical journal of experimental and clinical research, 16(2), CR92–CR95
Day, S. M., Duquaine, D., Mundada, L. V., Menon, R. G., Khan, B. V., Rajagopalan, S., & Fay, W. P. (2003). Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation, 107(20), 2601–2606. https://doi.org/10.1161/01.CIR.0000066910.02844.D0
Dijkstra, A., Lenters-Westra, E., de Kort, W., Bokhorst, A. G., Bilo, H. J., Slingerland, R. J., & Vos, M. J. (2017). Whole Blood Donation Affects the Interpretation of Hemoglobin A1c. PloS one, 12(1), e0170802. https://doi.org/10.1371/journal.pone.0170802
Dongiovanni, P., Fracanzani, A. L., Fargion, S., & Valenti, L. (2011). Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. Journal of hepatology, 55(4), 920–932. https://doi.org/10.1016/j.jhep.2011.05.008
Dorle, A., Gajbe, U., Singh, B. R., Noman, O., & Dawande, P. (2023). A Review of Amelioration of Awareness About Blood Donation Through Various Effective and Practical Strategies. Cureus, 15(10), e46892. https://doi.org/10.7759/cureus.46892
Du, Z., & Qin, Y. (2023). Dyslipidemia and Cardiovascular Disease: Current Knowledge, Existing Challenges, and New Opportunities for Management Strategies. Journal of clinical medicine, 12(1), 363. https://doi.org/10.3390/jcm12010363
Edgren, G., Reilly, M., Hjalgrim, H., Tran, T. N., Rostgaard, K., Adami, J., Titlestad, K., Shanwell, A., Melbye, M., & Nyrén, O. (2008). Donation frequency, iron loss, and risk of cancer among blood donors. Journal of the National Cancer Institute, 100(8), 572–579. https://doi.org/10.1093/jnci/djn084
Edgren, G., Tran, T. N., Hjalgrim, H., Rostgaard, K., Shanwell, A., Titlestad, K., Wikman, A., Norda, R., Jersild, C., Wideroff, L., Gridley, G., Adami, J., Melbye, M., Nyrén, O., & Reilly, M. (2007). Improving health profile of blood donors as a consequence of transfusion safety efforts. Transfusion, 47(11), 2017–2024. https://doi.org/10.1111/j.1537-2995.2007.01425.x
Eftekhari, M. H., Mozaffari-Khosravi, H., Shidfar, F., & Zamani, A. (2013). Relation between Body Iron Status and Cardiovascular Risk Factors in Patients with Cardiovascular Disease. International journal of preventive medicine, 4(8), 911–916
Ellervik, C., Marott, J. L., Tybjærg-Hansen, A., Schnohr, P., & Nordestgaard, B. G. (2014). Total and cause-specific mortality by moderately and markedly increased ferritin concentrations: general population study and metaanalysis. Clinical chemistry, 60(11), 1419–1428. https://doi.org/10.1373/ clinchem.2014.229013
Ferguson, E., Farrell, K., & Lawrence, C. (2008). Blood donation is an act of benevolence rather than altruism. Health psychology: official journal of the Division of Health Psychology, American Psychological Association, 27(3), 327–336. https://doi.org/10.1037/0278-6133.27.3.327
Fernández-Real, J. M., López-Bermejo, A., & Ricart, W. (2005). Iron stores, blood donation, and insulin sensitivity and secretion. Clinical chemistry, 51(7), 1201–1205. https://doi.org/10.1373/clinchem. 2004.046847
Finch, C. A., Cook, J. D., Labbe, R. F., & Culala, M. (1977). Effect of blood donation on iron stores as evaluated by serum ferritin. Blood, 50(3), 441–447
Galaris, D., Barbouti, A., & Pantopoulos, K. (2019). Iron homeostasis and oxidative stress: An intimate relationship. Biochimica et biophysica acta. Molecular cell research, 1866(12), 118535. https://doi.org/10.1016/j.bbamcr.2019.118535
Gasiorowski, R., Forbes, M. K., Silver, G., Krastev, Y., Hamdorf, B., Lewis, B., Tisbury, M., Cole-Sinclair, M., Lanphear, B. P., Klein, R. A., Holmes, N., & Taylor, M. P. (2022). Effect of Plasma and Blood Donations on Levels of Perfluoroalkyl and Polyfluoroalkyl Substances in Firefighters in Australia: A Randomized Clinical Trial. JAMA network open, 5(4), e226257. https://doi.org/10.1001/jamanet-workopen. 2022. 6257
Gasparovic Babic, S., Krsek, A., & Baticic, L. (2024). Voluntary Blood Donation in Modern Healthcare: Trends, Challenges, and Opportunities. Epidemiologia (Basel, Switzerland), 5(4), 770–784. https:// doi.org/10.3390/epidemiologia5040052
Gebre-Yohannes, A., & Rahlenbeck, S. I. (1998). Coronary heart disease risk factors among blood donors in northwest Ethiopia. East African medical journal, 75(9), 495–500
Germain, M., Delage, G., Blais, C., Maunsell, E., Décary, F., & Grégoire, Y. (2013). Iron and cardiac ischemia: a natural, quasi-random experiment comparing eligible with disqualified blood donors. Transfusion, 53(6), 1271–1279. https://doi.org/10.1111/trf.12081
Getta, H. A., Ahmad, H. A., Rahman, H. S., Ahmed, G. A., & Abdullah, R. (2018). Medical and laboratory assessment for regular blood donors in Sulaimani Blood Bank, Iraq. Patient preference and adherence, 12, 939–944. https://doi.org/10.2147/PPA.S157221
Goodnough, L. T., & Panigrahi, A. K. (2017). Blood Transfusion Therapy. The Medical clinics of North America, 101(2), 431–447. https://doi.org/10.1016/j.mcna.2016.09.012
Guo, Q., Qian, C., & Qian, Z. M. (2023). Iron metabolism and atherosclerosis. Trends in endocrinology and metabolism: TEM, 34(7), 404–413. https://doi.org/10.1016/j.tem.2023.04.003
Guo, S., Mao, X., Li, X., & Ouyang, H. (2022). Association between iron status and incident coronary artery disease: a population based-cohort study. Scientific reports, 12(1), 17490. https://doi.org/ 10.1038/s41598-022-22275-0
Gyuris, P., Gáspár, B. G., Birkás, B., Csókási, K., & Kocsor, F. (2021). Help Is in Your Blood-Incentive to “Double Altruism” Resolves the Plasma Donation Paradox. Frontiers in psychology, 12, 653848. https://doi.org/10.3389/fpsyg.2021.653848
Halliwell, B., & Gutteridge, J. M. (1986). Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Archives of biochemistry and biophysics, 246(2), 501–514. https://doi.org/10.1016/0003-9861(86)90305-x
Hann, H. W., Stahlhut, M. W., & Blumberg, B. S. (1988). Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cancer research, 48(15), 4168–4170
Hindawi, S., Badawi, M., Hussein, D., Al-Riyami, A. Z., Daghman, N. A., Rafie, N. I., Belgasm, N. M., Al Zaabi, E., & Oumeziane, N. (2021). The impact of blood donation on blood counts and ferritin levels: A multi-center study from the Eastern Mediterranean region. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis, 60(3), 103072. https://doi.org/10.1016/j.transci.2021.103072
Holay, M. P., Choudhary, A. A., & Suryawanshi, S. D. (2012). Serum ferritin-a novel risk factor in acute myocardial infarction. Indian heart journal, 64(2), 173–177. https://doi.org/10.1016/S0019-4832(12)60056-X
Holsworth, R. E., Jr, Cho, Y. I., Weidman, J. J., Sloop, G. D., & St Cyr, J. A. (2014). Cardiovascular benefits of phlebotomy: relationship to changes in hemorheological variables. Perfusion, 29(2), 102–116. https://doi.org/10.1177/0267659113505637
Houschyar, K. S., Lüdtke, R., Dobos, G. J., Kalus, U., Broecker-Preuss, M., Rampp, T., Brinkhaus, B., & Michalsen, A. (2012). Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial. BMC medicine, 10, 54. https://doi.org/ 10.1186/1741-7015-10-54
Huang, P. L. (2009). A comprehensive definition for metabolic syndrome. Disease models & mecha-nisms, 2(5-6), 231–237. https://doi.org/10.1242/dmm.001180
Huang, X. (2003). Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutation research, 533(1-2), 153–171. https://doi.org/10.1016/j.mrfmmm. 2003.08.023
Imam, M. U., Zhang, S., Ma, J., Wang, H., & Wang, F. (2017). Antioxidants Mediate Both Iron Homeo-stasis and Oxidative Stress. Nutrients, 9(7), 671. https://doi.org/10.3390/nu9070671
Infanti, L., Leitner, G., Moe, M., Pehlic, V., Cattaneo, M., Benkert, P., Holbro, A., Passweg, J., Worel, N., & Buser, A. (2024). Blood donation for iron removal in individuals with HFE mutations: study of efficacy and safety and short review on hemochromatosis and blood donation. Frontiers in medicine, 11, 1362941. https://doi.org/10.3389/fmed.2024.1362941
Ishii, K., Birmann, B. M., Zhang, X., Giovannucci, E., & Bertrand, K. A. (2016). A prospective analysis of blood donation history and risk of non-Hodgkin lymphoma. Leukemia & lymphoma, 57(6), 1423–1428. https://doi.org/10.3109/10428194.2015.1091928
Jiang, R., Ma, J., Ascherio, A., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2004). Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study. The American journal of clinical nutrition, 79(1), 70–75. https://doi.org/10.1093/ajcn/79.1.70
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023). Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Archives of toxicology, 97(10), 2499–2574. https://doi.org/10.1007/s00204-023-03562-9
Kadoglou, N. P. E., Biddulph, J. P., Rafnsson, S. B., Trivella, M., Nihoyannopoulos, P., & Demakakos, P. (2017). The association of ferritin with cardiovascular and all-cause mortality in community-dwellers: The English longitudinal study of ageing. PloS one, 12(6), e0178994. https://doi.org/ 10.1371/journal.pone.0178994
Kamhieh-Milz, S., Kamhieh-Milz, J., Tauchmann, Y., Ostermann, T., Shah, Y., Kalus, U., Salama, A., & Michalsen, A. (2016). Regular blood donation may help in the management of hypertension: an observational study on 292 blood donors. Transfusion, 56(3), 637–644. https://doi.org/10.1111/ trf.13428
Kaur, A., Kaur, R., Sood, T., Malhotra, A., Arun, P., Mittal, K., Kaur, P., Kaur, G., & Prakash, K. (2023). Physiological and psychological stress response of blood donors during the blood donation process. Vox sanguinis, 118(12), 1061–1068. https://doi.org/10.1111/vox.13541
Kebalo, A. H., Gizaw, S. T., Gnanasekaran, N., & Areda, B. G. (2022). Lipid and Haematologic Profiling of Regular Blood Donors Revealed Health Benefits. Journal of blood medicine, 13, 385–394. https://doi.org/10.2147/JBM.S367990
Khan, F., Singh, K., & Friedman, M. T. (2020). Artificial Blood: The History and Current Perspectives of Blood Substitutes. Discoveries (Craiova, Romania), 8(1), e104. https://doi.org/10.15190/d.2020.1
Kilani, N., Vollenweider, P., Waeber, G., & Marques-Vidal, P. (2015). Iron metabolism and incidence of metabolic syndrome. Nutrition, metabolism, and cardiovascular diseases: NMCD, 25(11), 1025–1032. https://doi.org/10.1016/j.numecd.2015.07.005
Kiss J. E. (2015). Laboratory and genetic assessment of iron deficiency in blood donors. Clinics in laboratory medicine, 35(1), 73–91. https://doi.org/10.1016/j.cll.2014.10.011
Knekt, P., Reunanen, A., Takkunen, H., Aromaa, A., Heliövaara, M., & Hakulinen, T. (1994). Body iron stores and risk of cancer. International journal of cancer, 56(3), 379–382. https://doi.org/10.1002/ ijc.2910560315
Kowdley K. V. (2004). Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology,
(5 Suppl. 1), S79–S86. https://doi.org/10.1016/j.gastro.2004.09.019
Krisai, P., Leib, S., Aeschbacher, S., Kofler, T., Assadian, M., Maseli, A., Todd, J., Estis, J., Risch, M., Risch, L., & Conen, D. (2016). Relationships of iron metabolism with insulin resistance and glucose levels in young and healthy adults. European journal of internal medicine, 32, 31–37. https://doi.org/ 10.1016/j.ejim.2016.03.017
Lasek, W., Jakobisiak, M., & Stoklosa, T. (1994). Decreased natural killer cell activity in whole-blood donors does not seem to result in increased cancer incidence. Transfusion, 34(4), 359–360. https://doi.org/10.1046/j.1537-2995.1994.34494233589.x
Li, S., & Zhang, X. (2021). Iron in Cardiovascular Disease: Challenges and Potentials. Frontiers in cardiovascular medicine, 8, 707138. https://doi.org/10.3389/fcvm.2021.707138
Liu, B. W., Xuan, X. M., Liu, J. R., Li, F. N., & Yin, F. Z. (2015). The Relationship between Serum Ferritin and Insulin Resistance in Different Glucose Metabolism in Nonobese Han Adults. International journal of endocrinology, 2015, 642194. https://doi.org/10.1155/2015/642194
Magnusson, M. K., Sigfusson, N., Sigvaldason, H., Johannesson, G. M., Magnusson, S., & Thorgeirsson, G. (1994). Low iron-binding capacity as a risk factor for myocardial infarction. Circulation, 89(1), 102–108. https://doi.org/10.1161/01.cir.89.1.102
Mahida, V. I., Bhatti, A., & Gupte, S. C. (2008). Iron status of regular voluntary blood donors. Asian journal of transfusion science, 2(1), 9–12. https://doi.org/10.4103/0973-6247.39504
Makowicz, D., Dziubaszewska, R., Lisowicz, K., & Makowicz, N. (2022). Impact of regular blood donation on the human body; donors’ perspective. Donors’ opinion on side effects of regular blood donation on human body. Journal of Transfusion Medicine, 15(2), 133-140. https://doi.org/10.5603/ JTM.2022.0011
Manascero-Gómez, A. R., Bravo-Espinosa, M., Solano-Muriel, K., & Poutou-Piñales, R. A. (2015). Influence of blood donation time intervals on ferritin and hemoglobin concentration. Transfusion and apheresis science: official journal of the World Apheresis Association: official journal of the European Society for Haemapheresis, 53(2), 213–219. https://doi.org/10.1016/j.transci.2015.03.020
Mantadakis, E., Panagopoulou, P., Kontekaki, E., Bezirgiannidou, Z., & Martinis, G. (2022). Iron Defi-ciency and Blood Donation: Links, Risks and Management. Journal of blood medicine, 13, 775–786. https://doi.org/10.2147/JBM.S375945
Marquet, R. L., Hoynck van Papendrecht, M. A., Busch, O. R., & Jeekel, J. (1993). Blood donation leads to a decrease in natural killer cell activity: a study in normal blood donors and cancer patients. Transfusion, 33(5), 368–373. https://doi.org/10.1046/j.1537-2995.1993.33593255594.x
Masenga, S. K., Kabwe, L. S., Chakulya, M., & Kirabo, A. (2023). Mechanisms of Oxidative Stress in Metabolic Syndrome. International journal of molecular sciences, 24(9), 7898. https://doi.org/ 10.3390/ijms24097898
Mast, A. E., Szabo, A., Stone, M., Cable, R. G., Spencer, B. R., Kiss, J. E., & NHLBI Recipient Epidemiology Donor Evaluation Study (REDS)-III (2020). The benefits of iron supplementation following blood donation vary with baseline iron status. American journal of hematology, 95(7), 784–791. https://doi.org/10.1002/ajh.25800
Merk, K., Mattsson, B., Mattsson, A., Holm, G., Gullbring, B., & Björkholm, M. (1990). The incidence of cancer among blood donors. International journal of epidemiology, 19(3), 505–509. https://doi.org/ 10.1093/ije/19.3.505
Meyers D. G. (2000). The iron hypothesis:does iron play a role in atherosclerosis?. Transfusion, 40(8), 1023–1029. https://doi.org/10.1046/j.1537-2995.2000.40081023.x.
Meyers, D. G., Jensen, K. C., & Menitove, J. E. (2002). A historical cohort study of the effect of lowering body iron through blood donation on incident cardiac events. Transfusion, 42(9), 1135–1139. https://doi.org/10.1046/j.1537-2995.2002.00186.x
Meyers, D. G., Strickland, D., Maloley, P. A., Seburg, J. K., Wilson, J. E., & McManus, B. F. (1997). Possible association of a reduction in cardiovascular events with blood donation. Heart (British Cardiac Society), 78(2), 188–193. https://doi.org/10.1136/hrt.78.2.188
Mills, K. T., Stefanescu, A., & He, J. (2020). The global epidemiology of hypertension. Nature reviews. Nephrology, 16(4), 223–237. https://doi.org/10.1038/s41581-019-0244-2
Milman N. (1996). Serum ferritin in Danes: studies of iron status from infancy to old age, during blood donation and pregnancy. International journal of hematology, 63(2), 103–135. https://doi.org/ 10.1016/0925-5710(95)00426-2
Milman, N., & Kirchhoff, M. (1991). The influence of blood donation on iron stores assessed by serum ferritin and hemoglobin in a population survey of 1359 Danish women. Annals of hematology, 63(1), 27–32. https://doi.org/10.1007/BF01714957
Müller, M., Ruf, E., Weinauer, F., Martin, S., Becker, C., Illig, T., Döring, A., Wichmann, H. E., & Rapp, S. (2009). Die BSD Gesundheitsstudie: eine Pilotstudie zur Untersuchung der Vergleichbarkeit bayerischer Blutspender mit der Allgemein-bevölkerung Bayerns durch einen Vergleich mit KORA S4 (The BSD Health Study: a pilot study to examine the comparability of Bavarian blood donors with the Bavarian general population by a comparison with KORA S4). Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 71(8-9), 481–488. https://doi.org/ 10.1055/s-0028-1119368
Muñoz-Bravo, C., Gutiérrez-Bedmar, M., Gómez-Aracena, J., García-Rodríguez, A., & Navajas, J. F. (2013). Iron: protector or risk factor for cardiovascular disease? Still controversial. Nutrients, 5(7), 2384–2404. https://doi.org/10.3390/nu5072384
Myers, D.J., Collins, R.A. Blood Donation. (Updated 2024 Oct 7). In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/ books/NBK525967/
Nadarajan, V. S., & Eow, G. I. (2002). Anaemia and iron status among blood donors in a blood transfusion unit in Malaysia. The Malaysian journal of pathology, 24(2), 99–102
Nelson R. L. (2001). Iron and colorectal cancer risk: human studies. Nutrition reviews, 59(5), 140–148. https://doi.org/10.1111/j.1753-4887.2001.tb07002.x
Nelson, R. L., Davis, F. G., Sutter, E., Sobin, L. H., Kikendall, J. W., & Bowen, P. (1994). Body iron stores and risk of colonic neoplasia. Journal of the National Cancer Institute, 86(6), 455–460. https:// doi.org/10.1093/jnci/86.6.455
Panieri, E., Baralic, K., Djukic-Cosic, D., Buha Djordjevic, A., & Saso, L. (2022). PFAS Molecules: A Major Concern for the Human Health and the Environment. Toxics, 10(2), 44. https://doi.org/10.3390/ toxics10020044
Pedrigi, R. M., de Silva, R., Bovens, S. M., Mehta, V. V., Petretto, E., & Krams, R. (2014). Thin-cap fibro-atheroma rupture is associated with a fine interplay of shear and wall stress. Arteriosclerosis, throm¬bosis, and vascular biology, 34(10), 2224–2231. https://doi.org/10.1161/ATVBAHA.114.303 426
Peffer, K., den Heijer, M., de Kort, W. L. A. M., Verbeek, A. L. M., & Atsma, F. (2019). Cardiovascular risk in 159 934 frequent blood donors while addressing the healthy donor effect. Heart (British Cardiac Society), 105(16), 1260–1265. https://doi.org/10.1136/heartjnl-2018-314138
Peritore, A. F., Gugliandolo, E., Cuzzocrea, S., Crupi, R., & Britti, D. (2023). Current Review of Increasing Animal Health Threat of Per- and Polyfluoroalkyl Substances (PFAS): Harms, Limitations, and Alternatives to Manage Their Toxicity. International journal of molecular sciences, 24(14), 11707. https://doi.org/10.3390/ijms241411707
Phaniendra, A., Jestadi, D. B., & Periyasamy, L. (2015). Free radicals: properties, sources, targets, and their implication in various diseases. Indian journal of clinical biochemistry: IJCB, 30(1), 11–26. https://doi.org/10.1007/s12291-014-0446-0
Przywileje Honorowego Dawcy Krwi (n.d.). Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w Gdańsku. Available from: https://www.rckik.wroclaw.pl/krwiodawstwo-Przywileje-Honorowego-Dawcy-Krwi-13-3.html
Przywileje Krwiodawców (n.d.). Regionalne Centrum Krwiodawstwa i Krwiolecznictwa w Gdańsku. Available from: https://krew.gda.pl/przywileje-krwiodawcow,295,pl.html
Piperno, A., Trombini, P., Gelosa, M., Mauri, V., Pecci, V., Vergani, A., Salvioni, A., Mariani, R., & Mancia, G. (2002). Increased serum ferritin is common in men with essential hypertension. Journal of hypertension, 20(8), 1513–1518. https://doi.org/10.1097/00004872-200208000-00013
Porter, J. L., & Rawla, P. Hemochromatosis. (Updated 2024 Oct 6). In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/ books/NBK430862/
Quee, F. A., Peffer, K., Ter Braake, A. D., & Van den Hurk, K. (2022). Cardiovascular Benefits for Blood Donors? A Systematic Review. Transfusion medicine reviews, 36(3), 143–151. https://doi.org/ 10.1016/j.tmrv.2022.04.004
Rahman, M. M., Hayen, A., Olynyk, J. K., Cust, A. E., Irving, D. O., & Karki, S. (2024). Regular whole blood donation and gastrointestinal, breast, colorectal and haematological cancer risk among blood donors in Australia. Vox sanguinis, 119(12), 1234–1244. https://doi.org/10.1111/vox.13734
Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., & Nishigaki, I. (2013). The vascular endothelium and human diseases. International journal of biological sciences, 9(10), 1057–1069. https://doi.org/10.7150/ijbs.7502
Ramakrishna, G., Rooke, T. W., & Cooper, L. T. (2003). Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light. Vascular medicine (London, England), 8(3), 203–210. https://doi.org/10.1191/1358863x03vm493ra
Reddy, K. V., Shastry, S., Raturi, M., & Baliga B, P. (2020). Impact of Regular Whole-Blood Donation on Body Iron Stores. Transfusion medicine and hemotherapy: offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 47(1), 75–79. https://doi.org/10.1159/000499768
Reddy, M. B., & Clark, L. (2004). Iron, oxidative stress, and disease risk. Nutrition reviews, 62(3), 120–124. https://doi.org/10.1111/j.1753-4887.2004.tb00033.x
Roemhild, K., von Maltzahn, F., Weiskirchen, R., Knüchel, R., von Stillfried, S., & Lammers, T. (2021). Iron metabolism: pathophysiology and pharmacology. Trends in pharmacological sciences, 42(8), 640–656. https://doi.org/10.1016/j.tips.2021.05.001
Rosa-Bray, M., Wisdom, C., Wada, S., Johnson, B. R., Grifols-Roura, V., & Grifols-Lucas, V. (2013). Prospective multicentre study of the effect of voluntary plasmapheresis on plasma cholesterol levels in donors. Vox sanguinis, 105(2), 108–115. https://doi.org/10.1111/vox.12031
Russo, G., Leopold, J. A., & Loscalzo, J. (2002). Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis. Vascular pharmacology, 38(5), 259–269. https://doi.org/10.1016/ s1537-1891(02)00250-1
Saklayen M. G. (2018). The Global Epidemic of the Metabolic Syndrome. Current hypertension reports, 20(2), 12. https://doi.org/10.1007/s11906-018-0812-z
Salonen, J. T., Korpela, H., Nyyssönen, K., Porkkala, E., Tuomainen, T. P., Belcher, J. D., Jacobs, D. R., Jr, & Salonen, R. (1995). Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers. Journal of internal medicine, 237(2), 161–168. https://doi.org/10.1111/j.1365-2796.1995.tb01156.x
Salonen, J. T., Nyyssönen, K., Korpela, H., Tuomilehto, J., Seppänen, R., & Salonen, R. (1992). High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation, 86(3), 803–811. https://doi.org/10.1161/01.cir.86.3.803
Salonen, J. T., Tuomainen, T. P., Salonen, R., Lakka, T. A., & Nyyssönen, K. (1998). Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. American journal of epidemiology, 148(5), 445–451. https://doi.org/10.1093/ oxfordjournals.aje.a009669
Sam, R. M., Shetty, S. S., Kumari N, S., Kp, S., & Bhandary, P. (2023). Association between iron profile status and insulin resistance in patients with type 2 diabetes mellitus. Journal of diabetes and metabolic disorders, 22(2), 1453–1458. https://doi.org/10.1007/s40200-023-01268-4
Samis A. J. (2008). Use of Blood Components in the Intensive Care Unit. Critical care medicine, 36(5), 1655–1656. https://doi.org/10.1097/CCM.0b013e318170157b
Sawicki, K. T., De Jesus, A., & Ardehali, H. (2023). Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets. Circulation research, 132(3), 379–396. https:// doi.org/10.1161/CIRCRESAHA.122.321667
Screening Donated Blood for Transfusion-Transmissible Infections: Recommendations. Geneva: World Health Organization; 2009. 4, Screening for transfusion-transmissible infections. Available from: https://www.ncbi.nlm.nih.gov/books/NBK142989/
Selby, J. V., & Friedman, G. D. (1988). Epidemiologic evidence of an association between body iron stores and risk of cancer. International journal of cancer, 41(5), 677–682. https://doi.org/10.1002/ ijc.2910410507
Shahjehan, R. D., Sharma, S., & Bhutta, B. S. Coronary Artery Disease. (Updated 2024 Oct 9). In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2025 Jan. Available from: https:// www.ncbi.nlm.nih.gov/books/NBK564304/
Sharkey-Toppen, T. P., Tewari, A. K., & Raman, S. V. (2014). Iron and atherosclerosis: nailing down a novel target with magnetic resonance. Journal of cardiovascular translational research, 7(5), 533–542. https://doi.org/10.1007/s12265-014-9551-y
Sheu, W. H., Chen, Y. T., Lee, W. J., Wang, C. W., & Lin, L. Y. (2003). A relationship between serum ferritin and the insulin resistance syndrome is present in non-diabetic women but not in non-diabetic men. Clinical endocrinology, 58(3), 380–385. https://doi.org/10.1046/j.1365-2265.2003.01729.x
Simcox, J. A., & McClain, D. A. (2013). Iron and diabetes risk. Cell metabolism, 17(3), 329–341. https://doi.org/10.1016/j.cmet.2013.02.007
Sloop G. D. (1998). Possible association of a reduction in cardiovascular events with blood donation. Heart (British Cardiac Society), 79(4), 422. https://doi.org/10.1136/hrt.79.4.422
Sloop, G., Holsworth, R. E., Jr, Weidman, J. J., & St Cyr, J. A. (2015). The role of chronic hyperviscosity in vascular disease. Therapeutic advances in cardiovascular disease, 9(1), 19–25. https://doi.org/ 10.1177/1753944714553226
Sullivan J. L. (1981). Iron and the sex difference in heart disease risk. Lancet (London, England), 1(8233), 1293–1294. https://doi.org/10.1016/s0140-6736(81)92463-6
Sun, L., Franco, O. H., Hu, F. B., Cai, L., Yu, Z., Li, H., Ye, X., Qi, Q., Wang, J., Pan, A., Liu, Y., & Lin, X. (2008). Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. The Journal of clinical endocrinology and metabolism, 93(12), 4690–4696. https://doi.org/10.1210/ jc.2008-1159
Taco-Vasquez, E. D., Barrera, F., Serrano-Duenas, M., Jimenez, E., Rocuts, A., & Riveros Perez, E. (2019). Association between Blood Viscosity and Cardiovascular Risk Factors in Patients with Arterial Hypertension in a High Altitude Setting. Cureus, 11(1), e3925. https://doi.org/10.7759/ cureus.3925
Thorpe, R., Masser, B., Coundouris, S. P., Hyde, M. K., Kruse, S. P., & Davison, T. E. (2024). The health impacts of blood donation: a systematic review of donor and non-donor perceptions. Blood transfusion = Trasfusione del sangue, 22(1), 7–19. https://doi.org/10.2450/BloodTransfus.494
Tiniakos, G., & Williams, R. (1988). Cirrhotic process, liver cell carcinoma and extrahepatic malignant tumors in idiopathic haemochromatosis. Study of 71 patients treated with venesection therapy. Applied pathology, 6(2), 128–138
Torti, S. V., Manz, D. H., Paul, B. T., Blanchette-Farra, N., & Torti, F. M. (2018). Iron and Cancer. Annual review of nutrition, 38, 97–125. https://doi.org/10.1146/annurev-nutr-082117-051732
Tuomainen, T. P., Salonen, R., Nyyssönen, K., & Salonen, J. T. (1997). Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ (Clinical research ed.), 314(7083), 793–794. https://doi.org/10.1136/bmj.314.7083.793
Uche, E., Adediran, A., Damulak, O., Adeyemo, T., Akinbami, A., & Akanmu, A. (2013). Lipid profile of regular blood donors. Journal of blood medicine, 4, 39–42. https://doi.org/10.2147/JBM.S42211
Vahidnia, F., Hirschler, N. V., Agapova, M., Chinn, A., Busch, M. P., & Custer, B. (2013). Cancer Incidence and Mortality in a Cohort of US Blood Donors: A 20-Year Study. Journal of cancer epidemiology, 2013, 814842. https://doi.org/10.1155/2013/814842
Valenti, L., Swinkels, D. W., Burdick, L., Dongiovanni, P., Tjalsma, H., Motta, B. M., Bertelli, C., Fatta, E., Bignamini, D., Rametta, R., Fargion, S., & Fracanzani, A. L. (2011). Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. Nutrition, metabolism, and cardiovascular diseases: NMCD, 21(8), 568–575. https://doi.org/10.1016/j.numecd.2010.01.003
van den Hurk, K., Zalpuri, S., Prinsze, F. J., Merz, E. M., & de Kort, W. L. A. M. (2017). Associations of health status with subsequent blood donor behavior-An alternative perspective on the Healthy Donor Effect from Donor InSight. PloS one, 12(10), e0186662. https://doi.org/10.1371/journal. pone.0186662
van Hinsbergh V. W. (2012). Endothelium--role in regulation of coagulation and inflammation. Seminars in immunopathology, 34(1), 93–106. https://doi.org/10.1007/s00281-011-0285-5
van Jaarsveld, H., & Pool, G. F. (2002). Beneficial effects of blood donation on high density lipoprotein concentration and the oxidative potential of low density lipoprotein. Atherosclerosis, 161(2), 395–402. https://doi.org/10.1016/s0021-9150(01)00638-4
Vari, I. S., Balkau, B., Kettaneh, A., André, P., Tichet, J., Fumeron, F., Caces, E., Marre, M., Grandchamp, B., Ducimetière, P., & DESIR Study Group (2007). Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes care, 30(7), 1795–1801. https://doi.org/10.2337/dc06-2312
Wang, X., Shen, Y., Shang, M., Liu, X., & Munn, L. L. (2023). Endothelial mechanobiology in athero-sclerosis. Cardiovascular research, 119(8), 1656–1675. https://doi.org/10.1093/cvr/cvad076
Wen, C. P., Lee, J. H., Tai, Y. P., Wen, C., Wu, S. B., Tsai, M. K., Hsieh, D. P., Chiang, H. C., Hsiung, C. A., Hsu, C. Y., & Wu, X. (2014). High serum iron is associated with increased cancer risk. Cancer research, 74(22), 6589–6597. https://doi.org/10.1158/0008-5472.CAN-14-0360
Williams, M. J., Poulton, R., & Williams, S. (2002). Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis, 165(1), 179–184. https://doi.org/10.1016/s0021-9150(02)00233-2
Xu, S., Ilyas, I., Little, P. J., Li, H., Kamato, D., Zheng, X., Luo, S., Li, Z., Liu, P., Han, J., Harding, I. C., Ebong, E. E., Cameron, S. J., Stewart, A. G., & Weng, J. (2021). Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacological reviews, 73(3), 924–967. https://doi.org/10.1124/pharmrev.120.000096
Xu, X., Liu, J., Huang, Y., & Han, X. (2024). Effect of iron status on myocardial infarction: A two-sample Mendelian randomization study. Heliyon, 10(24), e40516. https://doi.org/10.1016/j.heliyon.2024. e40516
Ying, J. F., Lu, Z. B., Fu, L. Q., Tong, Y., Wang, Z., Li, W. F., & Mou, X. Z. (2021). The role of iron homeostasis and iron-mediated ROS in cancer. American journal of cancer research, 11(5), 1895–1912
Yücel, H., Zorlu, A., Kaya, H., & Yılmaz, M. B. (2016). Regular blood donation improves endothelial function in adult males. Anatolian journal of cardiology, 16(3), 154–158. https://doi.org/10.5152/ akd.2015.6093
Yunce, M., Erdamar, H., Bayram, N. A., & Gok, S. (2016). One more health benefit of blood donation: reduces acute-phase reactants, oxidants and increases antioxidant capacity. Journal of basic and clinical physiology and pharmacology, 27(6), 653–657. https://doi.org/10.1515/jbcpp-2015-0111
Zacharski, L. R., Chow, B. K., Howes, P. S., Shamayeva, G., Baron, J. A., Dalman, R. L., Malenka, D. J., Ozaki, C. K., & Lavori, P. W. (2007). Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA, 297(6), 603–610. https:// doi.org/10.1001/jama.297.6.603
Zacharski, L. R., Chow, B. K., Howes, P. S., Shamayeva, G., Baron, J. A., Dalman, R. L., Malenka, D. J., Ozaki, C. K., & Lavori, P. W. (2008). Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. Journal of the National Cancer Institute, 100(14), 996–1002. https://doi.org/10.1093/jnci/djn209
Zeidan, R. S., Yoon, H. S., Yang, J. J., Sobh, A., Braithwaite, D., Mankowski, R., Leeuwenburgh, C., & Anton, S. (2024). Iron and cancer: overview of the evidence from population-based studies. Frontiers in oncology, 14, 1393195. https://doi.org/10.3389/fonc.2024.1393195
Zhang, X., Ma, J., Wu, K., Chan, A. T., Fuchs, C. S., & Giovannucci, E. L. (2012). Blood donation and colorectal cancer incidence and mortality in men. PloS one, 7(6), e39319. https://doi.org/10.1371/ journal.pone.0039319
Zhao, J., Dahlén, T., Brynolf, A., & Edgren, G. (2020). Risk of hematological malignancy in blood donors: A nationwide cohort study. Transfusion, 60(11), 2591–2596. https://doi.org/10.1111/trf.16020
Zheng, H., Cable, R., Spencer, B., Votto, N., & Katz, S. D. (2005). Iron stores and vascular function in voluntary blood donors. Arteriosclerosis, thrombosis, and vascular biology, 25(8), 1577–1583. https://doi.org/10.1161/01.ATV.0000174126.28201.61
Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014). Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiological reviews, 94(3), 909–950. https://doi.org/10.1152/ physrev.00026.2013
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Малгожата Градюк, Галина Ткаченко, Наталія Кургалюк
This work is licensed under a Creative Commons Attribution 4.0 International License.
